Gary Doolittle

3PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 23, 2026
Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

|Apr 22, 2022
Barriers to Clinical Trial Participation: Comparative Study Between Rural and Urban Participants.

Dinesh Pal Mudaranthakam, Byron Gajewski, Hope Krebill

|Oct 15, 2021
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma.

Merve Hasanov, Denái R Milton, William H Sharfman

Pageof 1

Frequent Collaborators

2 joint publications

Sapna Patel

1 joint publications

Megan Othus

1 joint publications

Thach-Giao Truong

1 joint publications

Elad Sharon